ALEC
Price
$2.12
Change
-$0.09 (-4.07%)
Updated
Sep 15, 10:51 AM (EDT)
Capitalization
247.88M
56 days until earnings call
Intraday BUY SELL Signals
BCYC
Price
$3.81
Change
-$0.08 (-2.06%)
Updated
Sep 15, 10:56 AM (EDT)
Capitalization
272.62M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALEC vs BCYC

ALEC vs BCYC Comparison Chart in %
View a ticker or compare two or three
VS
ALEC vs. BCYC commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Hold and BCYC is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($273M) has a higher market cap than ALEC($248M). ALEC YTD gains are higher at: 41.667 vs. BCYC (-45.056). ALEC has higher annual earnings (EBITDA): -117.76M vs. BCYC (-183.2M). BCYC has more cash in the bank: 510M vs. ALEC (173M). BCYC has less debt than ALEC: BCYC (14.7M) vs ALEC (32.8M). BCYC has higher revenues than ALEC: BCYC (61.2M) vs ALEC (13.9M).
ALECBCYCALEC / BCYC
Capitalization248M273M91%
EBITDA-117.76M-183.2M64%
Gain YTD41.667-45.056-92%
P/E RatioN/AN/A-
Revenue13.9M61.2M23%
Total Cash173M510M34%
Total Debt32.8M14.7M223%
FUNDAMENTALS RATINGS
ALEC vs BCYC: Fundamental Ratings
ALEC
BCYC
OUTLOOK RATING
1..100
8960
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
4774
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
n/a11

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (9) in the null industry is significantly better than the same rating for ALEC (77) in the Biotechnology industry. This means that BCYC’s stock grew significantly faster than ALEC’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as ALEC (100) in the Biotechnology industry. This means that BCYC’s stock grew similarly to ALEC’s over the last 12 months.

BCYC's SMR Rating (97) in the null industry is in the same range as ALEC (100) in the Biotechnology industry. This means that BCYC’s stock grew similarly to ALEC’s over the last 12 months.

ALEC's Price Growth Rating (47) in the Biotechnology industry is in the same range as BCYC (74) in the null industry. This means that ALEC’s stock grew similarly to BCYC’s over the last 12 months.

ALEC's P/E Growth Rating (91) in the Biotechnology industry is in the same range as BCYC (100) in the null industry. This means that ALEC’s stock grew similarly to BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECBCYC
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
COMPARISON
Comparison
Sep 15, 2026
Stock price -- (ALEC: $2.21 vs. BCYC: $3.89)
Brand notoriety: ALEC and BCYC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 172% vs. BCYC: 58%
Market capitalization -- ALEC: $247.88M vs. BCYC: $272.62M
ALEC [@Biotechnology] is valued at $247.88M. BCYC’s [@Biotechnology] market capitalization is $272.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $131.68B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green while BCYC’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • BCYC’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALEC and BCYC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while BCYC’s TA Score has 4 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 5 bearish.
  • BCYC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ALEC and BCYC are a bad buy in the short-term.

Price Growth

ALEC (@Biotechnology) experienced а -10.16% price change this week, while BCYC (@Biotechnology) price change was -9.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.85%. For the same industry, the average monthly price growth was -3.79%, and the average quarterly price growth was +6.70%.

Reported Earning Dates

ALEC is expected to report earnings on Nov 10, 2026.

BCYC is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-5.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ALEC
Daily Signal:
Gain/Loss:
BCYC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLVTX19.040.11
+0.58%
MFS Low Volatility Equity R6
HLGEX49.98N/A
N/A
JPMorgan Mid Cap Growth I
MEYWX10.71N/A
N/A
Manning & Napier Equity Series W
PGRCX48.77-0.17
-0.35%
BNY Mellon Worldwide Growth C
MNSQX25.31-0.19
-0.75%
Invesco Main Street Small Cap R5

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with ARCT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
+3.27%
ARCT - ALEC
62%
Loosely correlated
+3.80%
EDIT - ALEC
41%
Loosely correlated
+1.48%
CRBU - ALEC
40%
Loosely correlated
+1.57%
VYGR - ALEC
38%
Loosely correlated
N/A
BCYC - ALEC
36%
Loosely correlated
+0.78%
More

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with DNLI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+0.78%
DNLI - BCYC
48%
Loosely correlated
+0.62%
PCVX - BCYC
48%
Loosely correlated
+0.12%
MGTX - BCYC
47%
Loosely correlated
+0.70%
BHVN - BCYC
46%
Loosely correlated
-0.55%
NGNE - BCYC
46%
Loosely correlated
-0.76%
More